Geyser Brands Inc. (TSX-V: GYSR) ('Geyser Brands' or the 'Company') has elected to exercise its call option pursuant to the terms of an Investment Agreement dated April 17, 2020, as amended on June 3, 2020 (collectively, the 'Investment Agreement'), between the Company and Hanma Investment Group Co. Ltd. ('HMI') in order to repurchase the 3,500,000 Class A Common shares in the capital of Geyser Management Inc. ('GMI'). Pursuant to the terms of the Investment Agreement, the Company is returning the fully unused trade credit note dated June 3, 2020 in the sum of $2,000,000 Canadian dollars as full and final payment for the repurchase.

As a result of the repurchase, HMI will no longer be a shareholder of GMI, which will revert back to being a wholly owned subsidiary of the Company. 'Although Geyser remains optimistic about the future of the Asian cannabis market, the company has, for the moment, decided to focus on strategic growth of its Canadian operations,' stated Andrew Harris, CEO.

About Geyser Brands Geyser Brands Inc.

builds brands in the health and wellness space that focus on the benefits of cannabis to improve lives. Its Health Canada approved Licensed Production facility has cultivation, processing, research and sales licenses, allowing it to deliver proprietary delivery technologies, formulations, research partnerships and traceability in supply and distribution. Through its petbased platform, GMI has positioned itself as potentially the only Licensed Cannabis Producer dedicated to the global pet industry. Geyser continues to own and exploit its non-pet brands, including Apothecary Naturals, Apothecary Ink and STOND which providing consumers with hemp and plant based natural products.

Contact:

Email: aharris@geyserbrands.com

(C) 2020 Electronic News Publishing, source ENP Newswire